Related Experiment Video

Updated: Jul 20, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth

Kongming Wu1, Anping Li, Mahadev Rao

  • 1Kimmel Cancer Center, Department of Cancer Biology, Bluemle Life Sciences Building, Philadelphia, Pennsylvania 19107, USA.

Molecular and Cellular Biology
|September 19, 2006
PubMed

Insights

DACH1, a cell fate factor, inhibits breast cancer growth by blocking cell division and tumor expansion. Increased nuclear DACH1 expression in patients correlates with better survival, suggesting therapeutic potential.

Area of Science:

  • Developmental Biology
  • Cancer Biology
  • Molecular Genetics

Background:

  • Cellular proliferation is restricted by cell death, senescence, and tumor suppressors like pRb and p53.
  • Oncogenesis pathways often mirror aberrant embryogenesis processes.
  • The dachshund (dac), eyes absent (eya), eyeless, and sine oculis (so) gene network regulates metazoan cell fate determination, with dac acting as a co-integrator.

Purpose of the Study:

  • To investigate the role of DACH1 in inhibiting oncogene-mediated breast oncogenesis.
  • To elucidate the molecular mechanisms by which DACH1 affects breast cancer cell proliferation and tumor growth.
  • To assess the clinical relevance of DACH1 expression in breast cancer patient survival.

Main Methods:

  • Investigated DACH1's effect on breast cancer cell DNA synthesis, colony formation, and Matrigel growth in vitro.
  • Utilized genetic deletion studies to identify key factors in DACH1-mediated inhibition.
  • Analyzed nuclear DACH1 expression in over 2,000 breast cancer patients and correlated it with clinical outcomes.

Main Results:

  • DACH1 significantly inhibited oncogene-mediated breast oncogenesis, blocking cell DNA synthesis, colony formation, and tumor growth in mice.
  • Cyclin D1 was found to be essential for DACH1-mediated DNA synthesis inhibition.
  • DACH1 repressed cyclin D1 via a novel mechanism involving c-Jun and its alpha-helical DS domain, recruiting corepressors.
  • Increased nuclear DACH1 expression inversely correlated with cellular mitosis and predicted improved patient survival.

Conclusions:

  • DACH1 acts as a tumor suppressor in breast cancer by arresting proliferation and growth.
  • DACH1's mechanism involves repressing cyclin D1 through a novel pathway.
  • Nuclear DACH1 expression is a potential biomarker for improved breast cancer patient survival and suggests therapeutic avenues.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...